Cardlytics shareholders approve 2025 Equity Incentive Plan authorizing up to 15.7M shares

Cardlytics, Inc.

Plan authorizes 15,722,908 shares: 10M new shares plus prior plan reserves and returning shares.
Annual meeting results: Class I directors elected (Jon Francis, Scott Hill, Alex Mishurov).
Deloitte & Touche ratified as independent auditor for fiscal year 2025.
Non-binding advisory vote on named executive officer compensation approved.
Plan became effective immediately upon stockholder approval on May 20, 2025.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.